ÂÜÀòÂÒÂ×

Ellee de Groot is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors, currently serving as Chief Technology Officer at Brii Biosciences since August 2022. Prior roles include EVP of Operations at Alaunos Therapeutics and several key positions at Ziopharm Oncology, where Ellee held titles such as EVP and General Manager of Cell Therapy and SVP of Program Management. Additional experience includes leadership roles at Helsinn Therapeutics, Sapphire Therapeutics, Rejuvenon Corporation, Guilford Pharmaceuticals, and Shell Chemical Company. Educational qualifications include a Ph.D. in Chemical Engineering from Stanford University, an MBA from Rice Business, and a B.S. in Chemical Engineering from the Massachusetts Institute of Technology.